ArticleCancer immunology, immunotherapy : CII2023

Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study.

Yunchao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.